Ims Health GmbH, a prominent player in the healthcare analytics sector, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1954, the company has established itself as a leader in providing data-driven insights and solutions for the pharmaceutical and healthcare industries. Specialising in market access, commercial effectiveness, and real-world evidence, Ims Health offers unique products and services that empower clients to make informed decisions. Their innovative analytics platforms and comprehensive data sets are designed to enhance patient outcomes and optimise business strategies. With a strong market position, Ims Health has achieved notable milestones, including strategic partnerships and advancements in digital health technologies. The company continues to shape the future of healthcare analytics, driving efficiency and effectiveness in an ever-evolving industry landscape.
How does Ims Health GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ims Health GmbH's score of 75 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ims Health GmbH, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of IQVIA Holdings Inc., which means that any climate commitments or emissions data may be inherited from this parent organisation. As of now, Ims Health GmbH has not established its own reduction targets or climate pledges. However, it is important to note that the climate initiatives and performance metrics may be influenced by the broader sustainability strategies of IQVIA Holdings Inc., which operates at a higher corporate level. This includes potential commitments to the Science Based Targets initiative (SBTi) and other climate-related frameworks, although specific details on these initiatives for Ims Health GmbH are not available. In summary, while Ims Health GmbH does not currently provide emissions data or specific climate commitments, its environmental impact and strategies may be aligned with those of its parent company, IQVIA Holdings Inc. Further information may be required to assess the company's individual climate actions and performance.
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 43,577,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 48,394,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 45,222,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Ims Health GmbH's Scope 3 emissions, which increased by 14% last year and increased by approximately 966% since 2012, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ims Health GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.